Freedom Together Foundation Trims Stock Position in Agilent Technologies, Inc. (NYSE:A)

Freedom Together Foundation reduced its position in shares of Agilent Technologies, Inc. (NYSE:A) by 79.9% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 20,357 shares of the medical research company’s stock after selling 81,000 shares during the quarter. Agilent Technologies comprises approximately 0.3% of Freedom Together Foundation’s holdings, making the stock its 9th largest holding. Freedom Together Foundation’s holdings in Agilent Technologies were worth $2,735,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently modified their holdings of A. CKW Financial Group grew its stake in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock worth $25,000 after buying an additional 100 shares in the last quarter. Global X Japan Co. Ltd. lifted its holdings in shares of Agilent Technologies by 161.1% in the 4th quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 116 shares during the last quarter. Redwood Park Advisors LLC bought a new stake in Agilent Technologies during the fourth quarter worth approximately $27,000. Lee Danner & Bass Inc. purchased a new stake in Agilent Technologies during the fourth quarter valued at approximately $29,000. Finally, Hanson & Doremus Investment Management lifted its stake in shares of Agilent Technologies by 66.5% in the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock valued at $35,000 after purchasing an additional 105 shares during the last quarter.

Wall Street Analyst Weigh In

Several research firms recently weighed in on A. Wells Fargo & Company decreased their price target on Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a report on Thursday, April 17th. Jefferies Financial Group reduced their target price on shares of Agilent Technologies from $135.00 to $116.00 and set a “hold” rating on the stock in a research note on Monday, April 21st. Robert W. Baird dropped their price target on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a research note on Thursday, February 27th. TD Cowen increased their price objective on shares of Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research report on Thursday, April 10th. Finally, Barclays dropped their target price on Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a research report on Thursday, April 10th. Seven investment analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, Agilent Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $143.00.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of Agilent Technologies stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the transaction, the vice president now directly owns 21,786 shares of the company’s stock, valued at approximately $2,657,456.28. The trade was a 8.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Daniel K. Podolsky sold 1,819 shares of the stock in a transaction on Monday, March 31st. The shares were sold at an average price of $116.46, for a total value of $211,840.74. Following the sale, the director now owns 35,737 shares of the company’s stock, valued at approximately $4,161,931.02. This represents a 4.84 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Trading Down 1.6 %

A opened at $106.93 on Friday. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The stock’s fifty day moving average is $111.53 and its two-hundred day moving average is $128.80. The company has a market capitalization of $30.49 billion, a P/E ratio of 24.58, a PEG ratio of 3.06 and a beta of 1.27. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $155.35.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, beating the consensus estimate of $1.27 by $0.04. Agilent Technologies had a return on equity of 25.56% and a net margin of 19.27%. The firm had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Analysts forecast that Agilent Technologies, Inc. will post 5.54 earnings per share for the current year.

Agilent Technologies Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 23rd. Shareholders of record on Tuesday, April 1st were issued a dividend of $0.248 per share. The ex-dividend date was Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a yield of 0.93%. Agilent Technologies’s dividend payout ratio is currently 22.76%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.